The Valley Desk

NCT02000622 · Interventional trial

Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.

Overall registry status Completed

Phase 3

Conditions BRCA 1 Gene Mutation, BRCA 2 Gene Mutation, Breast Cancer Metastatic

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov